Company Overview and News

0
Wealth management: 4 rising suns in financial services space

2018-07-11 moneycontrol
The 2 decade old Indian wealth management industry seems to be coming of age. In line with global trends, wealth management and private banking is fast emerging as an attractive business model for many financial institutions in India.
EDELWEISS KMBKY MS.PRE MS.PRF MOTILALOFS MS.PRG IIFL 532922 532636 MS.PRA 532892 MS.PRI MS.PRK KOTAKBANK 500247 MS

0
Motilal Oswal Financial Services Limited - Trading Window

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Allotment of ESOP/ESPS

2018-07-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Updates

2018-06-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

7
Motilal Oswal: Investors with an appetite for some volatility can accumulate for the long term

2018-06-21 moneycontrol
2018 has been a difficult year so far for equities with the midcap index falling around 12 percent year-to-date. The fall in many midcap stocks is much sharper with prices eroding over 40-50 percent. Motilal Oswal Financial Services (MOFS) is one such stock which is down 47 percent from its 52-week high. Following the collapse, should investors nibble over this stock? The answer is yes.
ICICIBANK 532892 532174 IBN MOTILALOFS

0
Motilal Oswal Financial Services Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Updates

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services gains 4% on healthy earnings in Q4 led by brokerage, AMC

2018-05-22 moneycontrol
Motilal Oswal Financial Services share price rallied nearly 4 percent intraday Tuesday after the company reported healthy earnings growth in Q4.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Investor Presentation

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Financial Result Updates

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
Motilal Oswal Financial Services Limited - Dividend

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

0
IndiGo to take a long, hard look at strategy under new leadership

2018-04-30 livemint
New Delhi/Mumbai: India’s largest airline IndiGo will look to strengthen operational areas and customer interface ahead of scaling up international flights under a new leadership, two people aware of the company’s plans said.
INDIGO 532892 MOTILALOFS 539448

0
InterGlobe Aviation gains 2% even as Aditya Ghosh exits IndiGo

2018-04-30 moneycontrol
InterGlobe Aviation rallied over 2 percent in morning trade on Monday after the company over the weekend said Aditya Ghosh will step down as the President and Whole-Time Director of InterGlobe Aviation--which operates IndiGo airlines--from July 31.
INDIGO 532892 MOTILALOFS 539448

0
Motilal Oswal Financial Services Limited - Updates

2018-04-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532892 MOTILALOFS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...